| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2022 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 5,252 | $15.10 | $79,305.20 | -95.7% | +4.8% | -25.4% | |
| Sep 8, 2022 | ABT Abbott Laboratories | Manning Joseph J52 | Executive Vice President | Sell | 23,008 | $107.00 | $2,461,856.00 | -30.2% | -1.6% | -5.4% | |
| Sep 8, 2022 | ISRG Intuitive Surgical Inc | Johnson Amal M60 | Director | Sell | 6,375 | $210.76 | $1,343,584.16 | -36.2% | +24.8% | +38.8% | |
| Sep 8, 2022 | CTSO Cytosorbents Corp | Chan Phillip P.56 | Chief Executive Officer | Buy | 35,000 | $1.70 | $59,500.00 | +4.2% | -23.7% | +34.9% | |
| Sep 8, 2022 | RGEN Repligen Corp | Hunt Anthony75 | Chief Executive Officer | Sell | 26,402 | $224.73 | $5,933,438.25 | -1.7% | -25.0% | -28.9% | |
| Sep 8, 2022 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 6,725 | $90.94 | $611,571.50 | -9.7% | -24.0% | -22.5% | |
| Sep 8, 2022 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 20,000 | $55.33 | $1,106,557.51 | -2.1% | +10.8% | +7.6% | |
| Sep 7, 2022 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $12.89 | $257,800.00 | -0.3% | -7.9% | -47.7% | |
| Sep 7, 2022 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 5,800 | $175.17 | $1,015,986.00 | -9.5% | +16.2% | +55.7% | |
| Sep 7, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 5,000 | $1.35 | $6,769.00 | +2.5% | -5.9% | -43.5% | |
| Sep 7, 2022 | SRTS Sensus Healthcare, Inc. | Sardano Joseph C81 | Chief Executive Officer | Sell | 41,588 | $12.53 | $521,257.59 | -1.2% | -48.5% | -76.9% | |
| Sep 6, 2022 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 125,828 | $40.49 | $5,094,310.16 | -6.6% | +12.5% | +33.4% | |
| Sep 6, 2022 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,545 | $216.92 | $335,141.40 | -1.4% | -0.4% | -30.4% | |
| Sep 6, 2022 | INFU Infusystem Holdings, Inc | Whitman Kevin | VP And Controller | Sell | 2,642 | $7.65 | $20,211.30 | -37.8% | +15.2% | +29.3% | |
| Sep 6, 2022 | EW Edwards Lifesciences Corp | Wood Larry L67 | Cvp, Tavr | Sell | 7,242 | $89.00 | $644,538.00 | -3.5% | -17.1% | -13.6% | |
| Sep 6, 2022 | HAE Haemonetics Corp | Llorens Josep59 | EVP, Global Manufacturing | Sell | 101 | $73.78 | $7,451.78 | -0.6% | +17.0% | +22.5% | |
| Sep 6, 2022 | NVCR Novocure Ltd | Leonard Frank X76 | Chief Development Officer | Sell | 1,384 | $78.57 | $108,740.88 | -1.6% | -1.6% | -73.9% | |
| Sep 2, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 492 | $3.75 | $1,843.52 | - | -10.5% | -74.4% | |
| Sep 2, 2022 | NVCR Novocure Ltd | Cordova Ashley75 | Chief Financial Officer | Sell | 885 | $79.04 | $69,947.75 | -1.2% | +3.7% | -71.7% | |
| Sep 2, 2022 | NVCR Novocure Ltd | Burke William Patrick62 | Chief Human Resources Officer | Sell | 718 | $79.04 | $56,748.57 | -1.3% | +3.7% | -71.7% | |
| Sep 2, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 131 | $3.74 | $490.46 | - | -10.5% | -74.4% | |
| Sep 2, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 130 | $3.75 | $487.11 | - | -10.5% | -74.4% | |
| Sep 2, 2022 | NVCR Novocure Ltd | Groenhuysen Wilhelmus Cm65 | Chief Operating Officer | Sell | 296 | $79.04 | $23,394.95 | -0.2% | +3.7% | -71.7% | |
| Sep 2, 2022 | NVCR Novocure Ltd | Shah Pritesh75 | Chief Commercial Officer | Sell | 269 | $79.04 | $21,260.95 | -0.3% | +3.7% | -71.7% | |
| Sep 2, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 394 | $3.75 | $1,476.32 | - | -10.5% | -74.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.